Skip to content

Role Of Plant Gorakhmundi And Haritaki In Vatarakta(Gout) Rog.

A Comparative Pharmaco- Therapeutic Study Of Plant Munditika And Haritaki On Vatarakta - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/099251
Enrollment
90
Registered
2025-12-16
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M205- Other deformities of toe(s) (acquired)

Interventions

None listed

Sponsors

Govt. Ayurvedic College, Patna
Lead Sponsor
Utam Kumar
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: a. Patient willing for the research trial. b. Patients suffering from Vatarakta disease.

Exclusion criteria

Exclusion criteria: a. Patient whose age is less than 18 years and more than 60 years. b. Patients are not willing for trial and support. c. Patients having severe disease like AIDS, Cancer, T.B, Severe Heart disease, Jaundice, Renal failure, anxiety disorder. d. Patients who have been diagnosed to have similar but other disease like osteo arthritis, Rheumatoid arthritis etc. e. Pregnant and breast-feeding mother

Design outcomes

Primary

MeasureTime frame
1. To study the drug pharmacognosy for the drug identification. 2. To study Vatarakta disease in terms of its etio-pathology, clinical manifestation with possible co-relation to modern Gout disease. 3. To assess analytical and pharmacological study of the trial drugs Munditika and Haritaki. Timepoint: 60 DAYS

Secondary

MeasureTime frame
To evaluate the effect of Munditika churna and Haritaki Churna and their combined form in management of Vatarakta disease.Timepoint: 60 DAYS

Countries

India

Contacts

Public ContactMAHENDRA PRASAD SINGH

Govt. Ayurvedic College, Patna

mahendrakiran1959@gmail.com9431040125

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026